Study the Safety and Efficacy of Probiotics Use in Premature Infants
NCT ID: NCT01891604
Last Updated: 2017-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Mixture of New Probiotic Strains in Preterm Infants
NCT03701906
Probiotic Supplementation in Breastfed Newborn Infants
NCT02286999
Severe Necrotizing Enterocolitis in Preterm Newborns <1500g Using Probiotics
NCT02226263
The Impact of Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Premature Infants
NCT00810160
Milk Oriented Microbiota
NCT03222804
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PARALLEL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
breast milk with Bifidobacterium Longum subp. Infantis R0033
breast milk
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalized within 48 hours after birth
Exclusion Criteria
* perforation
* gastroschisis
* large omphalocele
* congenital diaphragmatic hernia
* major congenital heart defects
2 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lallemand Health Solutions
INDUSTRY
University of Manitoba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. James Friel
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
jamesfriel2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.